MedTrace Logo

Reliability Testing of Silverman-Andersen Retraction Score in Preterm Infants

NCT03199898 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-02-17

No results posted yet for this study

Summary

Depending on their gestational age, preterm infants need several weeks with different types of breathing-support due to immature development of the lungs, respiratory muscles, chest-wall and respiratory center in the brain. WHO's recommendation on interventions to improve preterm birth outcomes underline the need for more research on respiratory support in infants born preterm. This study will test inter-rater and intra-rater reliability of the Silverman-Andersen Retraction Score, which is a systematic clinical scoring tool for the respiratory work and the severity of respiratory distress in preterm infants. It will examine if there is consistency in the assessments done by doctors and nurses, and also if the observations correlate with technological monitoring. This easy to use scoring tool will help to determine the grade of respiratory distress, to assess respiratory exacerbation, to decide when to start weaning from respiratory support, and to give the best respiratory treatment to the child. This study will contribute to optimize care for preterm infants with respiratory distress.

Conditions

  • Premature Birth

Interventions

DIAGNOSTIC_TEST

Silverman-Andersen Retraction Score

The Silverman-Andersen Retraction Score (SAs) is used to assess severity of respiratory distress in newborn and preterm infants without respiratory support.The score comprises 4 inspiratory categories of movements (thoraco-abdominal, intercostal, xiphoid, and chin movements) and one expiratory category (grunting).

Sponsors & Collaborators

  • Norwegian University of Science and Technology

    collaborator OTHER

  • Helse Nord-Trøndelag HF

    collaborator OTHER

  • St. Olavs Hospital

    lead OTHER

Principal Investigators

  • Elisabeth Selvaag, md · St. Olavs Hospital

Eligibility

Min Age
2 Weeks
Max Age
2 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-30
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03199898 on ClinicalTrials.gov